X4 Pharmaceuticals
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell XFOR and other ETFs, options, and stocks.About XFOR
X4 Pharmaceuticals, Inc. is a biopharmaceutical company, which engages in the development and discovery of novel therapeutics for the treatment of rare diseases and those with limited treatment options. The firm is focused on mavorixafor which is being marketed in the U.S. under the trade name xolremdi.
XFOR Key Statistics
Stock Snapshot
With a market cap of 277.25M, X4 Pharmaceuticals(XFOR) trades at $3.50. The stock has a price-to-earnings ratio of -0.24.
During the trading session on 2025-11-06, X4 Pharmaceuticals(XFOR) shares reached a daily high of $3.70 and a low of $3.49. At a current price of $3.50, the stock is +0.3% higher than the low and still -5.4% under the high.
Trading volume for X4 Pharmaceuticals(XFOR) stock has reached 355.37K, versus its average volume of 3.06M.
The stock's 52-week range extends from a low of $1.35 to a high of $26.83.
The stock's 52-week range extends from a low of $1.35 to a high of $26.83.
XFOR News
X4 Pharmaceuticals (XFOR) came out with a quarterly loss of $0.69 per share versus the Zacks Consensus Estimate of a loss of $0.79. This compares to a loss of $...
Reports Q3 revenue $199,000, consensus $1.9M. “The third quarter of 2025 was a time of corporate restructuring at X4 with the start of a new leadership team and...